Title:
AUTOMATIC CONTROL BOARD
Document Type and Number:
WIPO Patent Application WO/2021/125262
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an automatic control board that is highly scalable and highly versatile. According to the present invention, an external control FPGA device is provided with: a command reception terminal that receives command data; a control output terminal that outputs an operation control signal; and a plurality of FPGA connection terminals. Data processing FPGA devices are connected in a one-to-one relationship to the plurality of FPGA connection terminals via data processing lines that are independent of a command transmission path which transmits a control command from an external command data reception unit to a control signal output unit, and which comprises the external command data reception unit, a command data line, the external control FPGA device, an operation control signal line, and the control signal output unit, wherein the data processing FPGA devices receive data to be processed from the external control FPGA device via the data processing lines, and output the processed data to the external control FPGA device.
Inventors:
HIRAMATSU YUJI (JP)
KINOSHITA YU (JP)
NONOGUCHI HIROFUMI (JP)
KINOSHITA YU (JP)
NONOGUCHI HIROFUMI (JP)
Application Number:
PCT/JP2020/047153
Publication Date:
June 24, 2021
Filing Date:
December 17, 2020
Export Citation:
Assignee:
YAMAHA MOTOR CO LTD (JP)
International Classes:
G05B19/042; B25J13/08
Foreign References:
| JP2019041324A | 2019-03-14 | |||
| JP2001322078A | 2001-11-20 | |||
| JP2014052781A | 2014-03-20 | |||
| JP2012190413A | 2012-10-04 | |||
| JP2009193321A | 2009-08-27 | |||
| JP2018194548A | 2018-12-06 | |||
| JP2005025599A | 2005-01-27 | |||
| CN103885919A | 2014-06-25 | |||
| CN107038134A | 2017-08-11 |
Attorney, Agent or Firm:
TASS MEISTER PATENT FIRM (JP)
Download PDF:
Previous Patent: THERAPEUTIC FOR HIGH-RISK MYELODYSPLASTIC SYNDROME
Next Patent: USE OF ANTIBODY-DRUG CONJUGATES AND ANTIBODIES FOR DRUG DELIVERY
Next Patent: USE OF ANTIBODY-DRUG CONJUGATES AND ANTIBODIES FOR DRUG DELIVERY